Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Investigation of Naltrexone for Pathological Gambling

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Center for Responsible Gaming
Information provided by (Responsible Party):
Marc Potenza, Yale University
ClinicalTrials.gov Identifier:
NCT01057862
First received: January 25, 2010
Last updated: April 11, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2016
  Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)